Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, today announced record revenues for the three and six-month periods ended June 30, 2006. The Company also reported increased revenue guidance for fiscal 2006, a result of stronger than expected sales from key promoted brands.
